11 results
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
Summary of Non-Insulin ... Used to Treat Diabetes ... #Diabetes #Pharmacology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
: Weight-Based Dosing ... Add sliding scale ... estimation #Weight #Based ... #pharmacology # ... endocrinology #diabetes
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Insulin Dosing Basics ... For type 2 diabetes ... usually, or weight-based ... for type 2 diabetes ... #Prescribing #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... appropriately • Weight-based ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... #Medications #pharmacology
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
ADA/KDIGO Consensus ... layered evidence-based ... pharmacologic therapies ... ADA #KDIGO #eGFR ... #Insulin #metformin
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... Summary Mechanisms ... cells, triggering insulin ... #Summary #DM2 # ... diabetes #endocrinology
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
for Type 1 Diabetes ... patients with type 1 diabetes ... They will also add ... SensitivityFactor #Type1 #Diabetes ... #DM1 #Pharmacology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... • Increases insulin-mediated ... #Summary #DM2 # ... diabetes #endocrinology
SNRls (Serotonin/Norepinephrine Reuptake Inhibitors) - FDA Approved Indications 

Venlafaxine (Effexor) - GAD, MDD, Panic Disorder, SAD
Inhibitors) - FDA ... Cymbalta) - GAD, MDD, Diabetic ... #Indications #Pharmacology ... #Psychiatry #FDA
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... glucose-dependent insulin ... #Summary #DM2 # ... diabetes #endocrinology